Cyramza 500mg/50ml, concentré pour solution de perfusion
7680652060022
CH-65206
Lösung
Associated product:
CYRAMZA conc perf 500 mg/50ml flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Lösung
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HIMDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
86.2 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2041.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2016
Authorization holder
Eli Lilly (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 65206
- Drug name
- Cyramza, concentré pour solution de perfusion
- Galenic form
- KOPA
- ATC Code
- L01FG02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 29/10/2015
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- CYRAMZA conc perf 500 mg/50ml flac
- Description (DE)
- CYRAMZA Inf Konz 500 mg/50ml Durchstf
- Market launch
- 29/10/2015
- Narcotic (BTM)
- No
Other package sizes (1)
CYRAMZA conc perf 100 mg/10ml flac
1 DUR
GTIN: 7680652060015